
RIGL EPS Estimates
Rigel Pharmaceuticals, Inc.
$41.44
-$1.09(-2.56%)
56
Overall
80
Value
27
Tech
63
Quality
Market Cap
$780.31M
Volume
119.96K
52W Range
$24.95 - $52.61
Target Price
$64.40
RIGL EPS estimates: the consensus estimate for Rigel Pharmaceuticals, Inc.'s current fiscal year is $2.97 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RIGL EPS Estimates
- EPS estimate, current quarter
- $0.89
- EPS estimate, next quarter
- $0.49
- EPS estimate, current year
- $2.97
- EPS estimate, next year
- $4.27
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2012 | $-1.32 |
| 2011 | $-13.60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RIGL | $41.44 | -2.6% | 119.96K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rigel Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW